Caregen Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 2/6

Caregen verzeichnete einen durchschnittlichen jährlichen Gewinnzuwachs von 10.5%, während die Gewinne der Branche Pharmaceuticals jährlich um gewachsen und zwar um 11.7%. Die Umsätze verzeichneten einen durchschnittlichen jährlichen Gewinnzuwachs von gewachsen von 7.8%. Die Eigenkapitalrendite von Caregen beträgt 15.2% und die Nettomargen betragen 44%.

Wichtige Informationen

10.5%

Wachstumsrate der Gewinne

8.0%

EPS-Wachstumsrate

Pharmaceuticals Wachstum der Industrie	11.3%
Wachstumsrate der Einnahmen	7.8%
Eigenkapitalrendite	15.2%
Netto-Marge	44.0%
Letzte Ertragsaktualisierung	30 Jun 2024

Jüngste Aktualisierungen vergangener Leistungen

Caregen (KOSDAQ:214370) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Mar 18

Recent updates

Why We're Not Concerned Yet About Caregen Co., Ltd.'s (KOSDAQ:214370) 26% Share Price Plunge

Aug 06

Caregen (KOSDAQ:214370) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Mar 18

With Caregen Co., Ltd. (KOSDAQ:214370) It Looks Like You'll Get What You Pay For

Mar 05

Do Its Financials Have Any Role To Play In Driving Caregen Co., Ltd.'s (KOSDAQ:214370) Stock Up Recently?

Jan 14

Caregen Co., Ltd. (KOSDAQ:214370) Goes Ex-Dividend Soon

Dec 25

Do Insiders Own Lots Of Shares In Caregen Co., Ltd. (KOSDAQ:214370)?

Dec 10

Is Caregen Co., Ltd. (KOSDAQ:214370) A Great Dividend Stock?

Nov 19

Aufschlüsselung der Einnahmen und Ausgaben

Wie Caregen Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.

Gewinn- und Umsatzhistorie

KOSDAQ:A214370 Einnahmen, Ausgaben und Erträge (KRW Millions)
Datum	Einnahmen	Umsatz	Allgemeine und Verwaltungskosten	F&E-Ausgaben
30 Jun 24	77,067	33,894	10,837	6,288
31 Mar 24	74,987	35,305	10,871	5,855
31 Dec 23	79,210	39,930	10,275	5,824
30 Sep 23	80,905	37,332	10,469	6,147
30 Jun 23	80,498	33,814	11,395	7,610
31 Mar 23	78,476	33,885	11,046	6,677
31 Dec 22	69,098	27,267	10,799	6,285
30 Sep 22	64,988	25,739	10,278	6,616
30 Jun 22	60,327	26,018	10,076	4,760
31 Mar 22	59,179	25,163	10,485	4,931
31 Dec 21	59,088	25,318	10,808	5,026
30 Sep 21	61,570	31,652	11,728	3,576
30 Jun 21	62,639	31,579	10,798	3,804
31 Mar 21	61,537	32,156	10,670	4,079
31 Dec 20	60,295	31,478	11,374	3,839
30 Sep 20	63,720	28,363	9,498	4,704
30 Jun 20	63,817	28,356	10,496	4,360
31 Mar 20	63,357	27,394	13,089	4,152
31 Dec 19	64,699	28,070	12,518	4,297
30 Sep 19	49,399	13,618	12,888	4,413
30 Jun 19	46,897	12,120	11,624	4,111
31 Mar 19	52,820	17,607	8,583	3,808
31 Dec 18	51,211	16,491	8,164	3,627
30 Sep 18	52,531	24,401	6,666	2,675
30 Jun 18	51,965	24,556	7,259	2,784
31 Mar 18	50,144	23,281	7,886	3,006
31 Dec 17	46,531	18,426	7,912	3,023
30 Sep 17	39,469	15,377	9,012	3,599
30 Jun 17	34,784	11,412	8,401	3,426
31 Mar 17	32,668	9,655	7,543	3,417
31 Dec 16	30,905	11,569	7,637	3,253
30 Jun 16	35,438	15,404	7,368	2,911
31 Dec 15	30,234	12,811	6,536	2,251

Qualität der Erträge: A214370 einen hohen Anteil an unbarem Gewinn hat.

Wachsende Gewinnspanne: A214370Die aktuellen Gewinnspannen (44%) sind höher als im letzten Jahr (42%).

Analyse von freiem Cashflow und Gewinn

Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: A214370In den letzten 5 Jahren sind die Gewinne von 10.5% jährlich gestiegen.

Beschleunigtes Wachstum: A214370Das Gewinnwachstum des Unternehmens im letzten Jahr (0.2%) liegt unter seinem 5-Jahres-Durchschnitt (10.5% pro Jahr).

Erträge im Vergleich zur Industrie: A214370 Das Gewinnwachstum im vergangenen Jahr (0.2%) übertraf nicht die Entwicklung der Branche Pharmaceuticals 21.9% .

Eigenkapitalrendite

Hohe Eigenkapitalrendite: A214370Die Eigenkapitalrendite des Unternehmens (15.2%) wird als niedrig angesehen.

Caregen Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 2/6

Wichtige Informationen

Jüngste Aktualisierungen vergangener Leistungen

Caregen Co., Ltd. to Report First Half, 2024 Results on Aug 02, 2024

First quarter 2024 earnings released: EPS: ₩194 (vs ₩288 in 1Q 2023)

Caregen Co., Ltd. to Report Q1, 2024 Results on May 10, 2024

Caregen (KOSDAQ:214370) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Full year 2023 earnings released: EPS: ₩813 (vs ₩556 in FY 2022)

Third quarter 2023 earnings released: EPS: ₩199 (vs ₩128 in 3Q 2022)

Recent updates

Investor sentiment improves as stock rises 17%

New major risk - Dividend sustainability

Consensus EPS estimates fall by 18%

Why We're Not Concerned Yet About Caregen Co., Ltd.'s (KOSDAQ:214370) 26% Share Price Plunge

Investor sentiment deteriorates as stock falls 28%

New minor risk - Share price stability

Caregen Co., Ltd. to Report First Half, 2024 Results on Aug 02, 2024

First quarter 2024 earnings released: EPS: ₩194 (vs ₩288 in 1Q 2023)

Caregen Co., Ltd. to Report Q1, 2024 Results on May 10, 2024

Caregen (KOSDAQ:214370) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Full year 2023 earnings released: EPS: ₩813 (vs ₩556 in FY 2022)

Investor sentiment improves as stock rises 16%

With Caregen Co., Ltd. (KOSDAQ:214370) It Looks Like You'll Get What You Pay For

Investor sentiment improves as stock rises 16%

Upcoming dividend of ₩340 per share at 2.0% yield

Third quarter 2023 earnings released: EPS: ₩199 (vs ₩128 in 3Q 2022)

Investor sentiment deteriorates as stock falls 19%

Caregen Co., Ltd. to Report Q3, 2023 Results on Nov 10, 2023

Investor sentiment deteriorates as stock falls 19%

Now 21% undervalued after recent price drop

Price target increased by 7.4% to ₩58,000

Caregen Co., Ltd. to Report Q2, 2023 Results on Aug 09, 2023

Now 24% undervalued

Upcoming dividend of ₩1,000 per share at 1.2% yield

New minor risk - Share price stability

Investor sentiment improves as stock rises 18%

First quarter 2023 earnings released: EPS: ₩1,440 (vs ₩768 in 1Q 2022)

Investor sentiment improves as stock rises 16%

Investor sentiment improves as stock rises 19%

Full year 2022 earnings released: EPS: ₩2,778 (vs ₩2,582 in FY 2021)

Investor sentiment improves as stock rises 28%

Investor sentiment improved over the past week

Upcoming dividend of ₩1,500 per share

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: ₩640 (vs ₩669 in 3Q 2021)

Third quarter 2022 earnings released: EPS: ₩640 (vs ₩669 in 3Q 2021)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Upcoming dividend of ₩800 per share

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Upcoming dividend of ₩1,300 per share

Upcoming dividend of ₩700 per share

A Look At The Fair Value Of Caregen Co., Ltd. (KOSDAQ:214370)

Here's How We Evaluate Caregen Co., Ltd.'s (KOSDAQ:214370) Dividend

Caregen (KOSDAQ:214370) Is Growing Earnings But Are They A Good Guide?

Caregen Co., Ltd. to Report Fiscal Year 2020 Results on Feb 10, 2021

Do Its Financials Have Any Role To Play In Driving Caregen Co., Ltd.'s (KOSDAQ:214370) Stock Up Recently?

New 90-day high: ₩76,300

Caregen Co., Ltd. (KOSDAQ:214370) Goes Ex-Dividend Soon

Do Insiders Own Lots Of Shares In Caregen Co., Ltd. (KOSDAQ:214370)?

New 90-day high: ₩71,400

New 90-day high: ₩66,400

Is Caregen Co., Ltd. (KOSDAQ:214370) A Great Dividend Stock?

New 90-day low: ₩60,400

Aufschlüsselung der Einnahmen und Ausgaben

Gewinn- und Umsatzhistorie

Analyse von freiem Cashflow und Gewinn

Analyse des Gewinnwachstums in der Vergangenheit

Eigenkapitalrendite

Kapitalrendite

Rendite auf das eingesetzte Kapital

Entdecken Sie starke Unternehmen, die in der Vergangenheit erfolgreich waren